Autolus Therapeutics plc Quarterly Depreciation in USD from Q2 2018 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Autolus Therapeutics plc quarterly/annual Depreciation history and growth rate from Q2 2018 to Q2 2025.
  • Autolus Therapeutics plc Depreciation for the quarter ending June 30, 2025 was $2.1M, a 10.5% increase year-over-year.
  • Autolus Therapeutics plc Depreciation for the twelve months ending June 30, 2025 was $8M, a 15.9% increase year-over-year.
  • Autolus Therapeutics plc annual Depreciation for 2024 was $7.6M, a 15.2% increase from 2023.
  • Autolus Therapeutics plc annual Depreciation for 2023 was $6.6M, a 9.59% decline from 2022.
  • Autolus Therapeutics plc annual Depreciation for 2022 was $7.3M, a 15.1% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $8M $2.1M +$200K +10.5% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $7.8M $2M +$200K +11.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $7.6M $2M +$200K +11.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-20
Q3 2024 $7.4M $1.9M +$500K +35.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $6.9M $1.9M +$400K +26.7% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $6.5M $1.8M -$100K -5.26% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $6.6M $1.8M Oct 1, 2023 Dec 31, 2023 10-K 2025-03-20
Q3 2023 $1.4M -$400K -22.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $1.5M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.9M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q3 2022 $1.8M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q1 2021 $6.2M $1.8M +$500K +38.5% Jan 1, 2021 Mar 31, 2021 6-K 2021-05-06
Q4 2020 $5.7M $1.7M +$400K +30.8% Oct 1, 2020 Dec 31, 2020 20-F 2023-03-07
Q3 2020 $5.3M $1.5M +$400K +36.4% Jul 1, 2020 Sep 30, 2020 6-K 2020-11-05
Q2 2020 $4.9M $1.2M +$100K +9.09% Apr 1, 2020 Jun 30, 2020 6-K 2020-08-06
Q1 2020 $4.8M $1.3M +$200K +18.2% Jan 1, 2020 Mar 31, 2020 6-K 2021-05-06
Q4 2019 $4.6M $1.3M +$655K +102% Oct 1, 2019 Dec 31, 2019 20-F 2022-03-10
Q3 2019 $3.95M $1.1M +$800K +267% Jul 1, 2019 Sep 30, 2019 6-K 2020-11-05
Q2 2019 $3.15M $1.1M +$600K +120% Apr 1, 2019 Jun 30, 2019 6-K 2020-08-06
Q1 2019 $2.55M $1.1M Jan 1, 2019 Mar 31, 2019 6-K 2020-05-07
Q4 2018 $645K Oct 1, 2018 Dec 31, 2018 20-F 2021-03-04
Q3 2018 $300K Jul 1, 2018 Sep 30, 2018 6-K 2019-11-07
Q2 2018 $500K Apr 1, 2018 Jun 30, 2018 6-K 2019-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.